RE:Undervalued and waitingWell said Gramps. 2019 has just begun. We must think of this as a new beginning for Aphria. The street will soon forget the terrible year that 2018 brought us. Time heals all wounds as they say.
grampanic wrote: Investors in Aphria have been in a waiting mode for a long time. Always asking themselves, why are we undervalued and underappreciated as compared to our peers. But as time and events have shown, the CEO could not raise the company to the next level. In a dynamic and rapidly changing industry the first mover advantage is important but VIc could not raise the bar to quickly move up and retain shareholder confidence in his moves.
So shareholders that have endured can now focus on a new day. Irwin Simon and the board will no doubt have to review various options in terms of hostile or friendly offers. Certainly there are any number of catalysts that can come. And you never know when!
The APHA board has no control over when health Canada will issue their approval for phase 4 and diamond. They have no control over unsolicited offers. But they can influence market sentiment by completing a new CEO search as quickly and comprehensively as possible. At the moment there is no real spokesperson for Aphria except for Irwin Simon. Vic Neufeld, while still CEO has no credibility with the market.
A polished CEO can quickly restore confidence and project a strong vision for Aphria to media and shareholders alike. It is sorely needed. So we patiently wait!